<?xml version="1.0" encoding="utf-8" standalone="no"?>
<dublin_core schema="dc">
<dcvalue element="contributor" qualifier="author">Kim,&#x20;Hye-Jung</dcvalue>
<dcvalue element="contributor" qualifier="author">Park,&#x20;Woo-Kyu</dcvalue>
<dcvalue element="contributor" qualifier="author">Cho,&#x20;Yong&#x20;Seo</dcvalue>
<dcvalue element="contributor" qualifier="author">No,&#x20;Kyoung&#x20;Tai</dcvalue>
<dcvalue element="contributor" qualifier="author">Koh,&#x20;Hun&#x20;Yeong</dcvalue>
<dcvalue element="contributor" qualifier="author">Choo,&#x20;Hyunah</dcvalue>
<dcvalue element="contributor" qualifier="author">Pae,&#x20;Ae&#x20;Nim</dcvalue>
<dcvalue element="date" qualifier="accessioned">2024-01-21T00:01:35Z</dcvalue>
<dcvalue element="date" qualifier="available">2024-01-21T00:01:35Z</dcvalue>
<dcvalue element="date" qualifier="created">2021-08-31</dcvalue>
<dcvalue element="date" qualifier="issued">2008-01-20</dcvalue>
<dcvalue element="identifier" qualifier="issn">0253-2964</dcvalue>
<dcvalue element="identifier" qualifier="uri">https:&#x2F;&#x2F;pubs.kist.re.kr&#x2F;handle&#x2F;201004&#x2F;133816</dcvalue>
<dcvalue element="description" qualifier="abstract">A&#x20;piperazinylalkylisoxazole&#x20;library&#x20;containing&#x20;86&#x20;compounds&#x20;was&#x20;constructed&#x20;and&#x20;evaluated&#x20;for&#x20;the&#x20;binding&#x20;affinities&#x20;to&#x20;dopamine&#x20;(D-3)&#x20;and&#x20;serotonin&#x20;(5-HT2A&#x2F;2C)&#x20;receptor&#x20;to&#x20;develop&#x20;antipsychotics.&#x20;Dopamine&#x20;antagonists&#x20;(DA)&#x20;showing&#x20;selectivity&#x20;for&#x20;D3&#x20;receptor&#x20;over&#x20;the&#x20;D2&#x20;receptor,&#x20;serotonin&#x20;antagonists&#x20;(SA),&#x20;and&#x20;serotonin-dopamine&#x20;dual&#x20;antagonists&#x20;(SDA)&#x20;were&#x20;identified&#x20;based&#x20;on&#x20;their&#x20;binding&#x20;affinity&#x20;and&#x20;selectivity.&#x20;The&#x20;analogues&#x20;were&#x20;divided&#x20;into&#x20;three&#x20;groups&#x20;of&#x20;7&#x20;DAs&#x20;(D-3)&#x20;33&#x20;SAS&#x20;(5-HT2A&#x2F;2C),&#x20;and&#x20;46&#x20;SDAs&#x20;(D-3&#x20;and&#x20;5-HT2A&#x2F;2C).&#x20;A&#x20;classification&#x20;model&#x20;was&#x20;generated&#x20;for&#x20;identifying&#x20;structural&#x20;characteristics&#x20;of&#x20;those&#x20;antagonists&#x20;with&#x20;different&#x20;affinity&#x20;profiles.&#x20;On&#x20;the&#x20;basis&#x20;of&#x20;the&#x20;results&#x20;from&#x20;our&#x20;previous&#x20;study,&#x20;we&#x20;conducted&#x20;the&#x20;generation&#x20;of&#x20;the&#x20;decision&#x20;trees&#x20;by&#x20;the&#x20;recursive-partitioning&#x20;(RP)&#x20;method&#x20;using&#x20;Cerius2&#x20;2D&#x20;descriptors,&#x20;and&#x20;identified&#x20;and&#x20;interpreted&#x20;the&#x20;descriptors&#x20;that&#x20;discriminate&#x20;in-house&#x20;antipsychotic&#x20;compounds.</dcvalue>
<dcvalue element="language" qualifier="none">English</dcvalue>
<dcvalue element="publisher" qualifier="none">KOREAN&#x20;CHEMICAL&#x20;SOC</dcvalue>
<dcvalue element="subject" qualifier="none">DOPAMINE</dcvalue>
<dcvalue element="subject" qualifier="none">RECEPTORS</dcvalue>
<dcvalue element="subject" qualifier="none">SCHIZOPHRENIA</dcvalue>
<dcvalue element="subject" qualifier="none">CLOZAPINE</dcvalue>
<dcvalue element="subject" qualifier="none">SEROTONIN</dcvalue>
<dcvalue element="subject" qualifier="none">BINDING</dcvalue>
<dcvalue element="subject" qualifier="none">DRUGS</dcvalue>
<dcvalue element="title" qualifier="none">Classification&#x20;of&#x20;piperazinylalkylisoxazole&#x20;library&#x20;by&#x20;recursive&#x20;partitioning</dcvalue>
<dcvalue element="type" qualifier="none">Article</dcvalue>
<dcvalue element="description" qualifier="journalClass">1</dcvalue>
<dcvalue element="identifier" qualifier="bibliographicCitation">BULLETIN&#x20;OF&#x20;THE&#x20;KOREAN&#x20;CHEMICAL&#x20;SOCIETY,&#x20;v.29,&#x20;no.1,&#x20;pp.111&#x20;-&#x20;116</dcvalue>
<dcvalue element="citation" qualifier="title">BULLETIN&#x20;OF&#x20;THE&#x20;KOREAN&#x20;CHEMICAL&#x20;SOCIETY</dcvalue>
<dcvalue element="citation" qualifier="volume">29</dcvalue>
<dcvalue element="citation" qualifier="number">1</dcvalue>
<dcvalue element="citation" qualifier="startPage">111</dcvalue>
<dcvalue element="citation" qualifier="endPage">116</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">scie</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">scopus</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">kci</dcvalue>
<dcvalue element="identifier" qualifier="kciid">ART001222731</dcvalue>
<dcvalue element="identifier" qualifier="wosid">000254186400019</dcvalue>
<dcvalue element="identifier" qualifier="scopusid">2-s2.0-38949188978</dcvalue>
<dcvalue element="relation" qualifier="journalWebOfScienceCategory">Chemistry,&#x20;Multidisciplinary</dcvalue>
<dcvalue element="relation" qualifier="journalResearchArea">Chemistry</dcvalue>
<dcvalue element="type" qualifier="docType">Article</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">DOPAMINE</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">RECEPTORS</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">SCHIZOPHRENIA</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">CLOZAPINE</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">SEROTONIN</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">BINDING</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">DRUGS</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">serotonin</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">dopamine&#x20;antagonist</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">classification</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">recursive&#x20;partitioning</dcvalue>
</dublin_core>
